Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium thiosulfate for calciphylaxis
ISRCTN73380053Phase 3Completed
- Sponsor
- Franz Köhler Chemie
- Start
- Apr 2016
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of sodium thiosulfate in calciphylaxis (CUA), sponsored by Franz Köhler Chemie. Primary endpoint: Percent reduction of total wound area at 24 weeks. Started Apr 2016; status: completed.
02
Drugs
sodium thiosulfate
03
Conditions
calciphylaxis (CUA)
Beyond the preview
Go deeper on ISRCTN73380053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN73380053.